Table of Contents Mechanism of Pernicious Anemia Pernicious anemia is commonly caused by a deficiency of intrinsic factor, a protein produced by the stomach that is necessary for vitamin B12 absorption in the small intestine
This gap comes down to rent, staffing, and the "luxury" experience
Shampoo: Orgainc Aloe Barbadensis Leaf Juice, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Sodium Cocoyl Isethionate, Glycerin, Caffeine, MSM, Biotin, Pantothenic Acid, PEPTASTEM [Citrus Aurantium Dulcis (Orange) Callus Culture Extract, Centella Asiatica (Gotu Kola) Extract, Tripeptide-5, Palmitoyl Tetrapeptide-7, Acetyl Hexapeptide-8, sh-Oligopeptide1, Allantoin] , Hydrolyzed Keratin, Vitis Vinifera Fruit Cell Extract (Grape Stem Cell), L-Methionine, Myristoyl Pentapeptide-17, Fucus Vesiculosus (Seaweed) Extract, Clitoria ternatea Linn Extract, Niacin, Simmondsia Chinensis (Jojoba) Seed Oil, Brassicamidopropyl Dimethylamine, Arthrospira Platensis, Peppermint (Mentha) Oil, Lavender (Lavendula) Oil, Sage (Salvia officinalis L.) Oil, Bergamot (Citrus Bergamia) Oil, Tocopheryl (Vitamin E), Ethoxydiglycol, Caprylyl Glycol, Xanthan Gum, Guar Hydroxypropyltrimonium Chloride, Sodium Benzoate, Potassium Sorbate, GHK-Cu (Copper Peptide), Radish ferment, Sodium Chloride, Tetrasodium Glutamate Diacetate Scalp Serum: Orgainc Aloe Barbadensis Leaf Juice, Stinging Nettle Hydrosol, Glycerin, Hydrolized Hyaluronic Acid, Pentylene Glycol, Caffeine, Glyciene, Soy Peptide, Silica, L-Methionine, Pyridoxine, Glutamic Acid, Copper Peptide(GHK-cu), Vitamin B12, Melatonin, Biotin, Centella Asiatica Extract, Acetyl Hexapeptide-8, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Allantoin, Pantothenic Acid, Hydrolyzed Keratin, Saw Palmetto, L-Arginine, Vitis Vinifera Fruit Cell Extract (Grape Stem Cell ), Myristoyl Pentapeptide-17, Ethyl Ascorbic Acid, Niacin, Zinc, Lactobacillus, Bourdock Extract, Catalase, Sodium Chloride, Disodium DHA, Methylsulfonylmethane, Propanedil, Lactic Acid, Ethylhexylglycerin
Schedule your consultation with Dr DiFrancesco to hear more about your options
16 (3), BR8188
dose-dependent response across 3, 6, and 9 mg arms Phase 3 T2D : HbA1c reductions up to 2.15% versus placebo in Chinese population trials Phase 1b/2 data : Earlier dose-finding studies establishing the efficacy and tolerability profile Global development : Ongoing clinical trials outside China, but no FDA approval or submission as of early 2026 Limitation : Primary clinical data from Chinese population
